Introduction
The presence of circulating antibodies to defined target autoantigens is characteristic of many organ-specific autoimmune disorders. An accurate investigation of these autoantibodies has relevant implications for their diagnostic, prognostic, and predictive value.
Various techniques are currently used to detect autoantibodies, including liquid-phase radio binding assay (RBA), solid-phase enzymatic immunoassay (EIA), indirect immunofluorescence (In), and a number of other immunoassays.
In Type I insulin-dependent diabetes mellitus it is widely agreed that destruction of the pancreatic b-cells is mediated by an autoimmune mechanism (13,15,21). Islet cell antibodies (ICA), detected by I n on human pancreatic cryosections, are a sensitive and specific serological marker of Type I diabetes (14) , being found in up to 90% of patients at the time of diagnosis (34). Several prospective studies performed in populations of individuals at risk have demonstrated that ICA can also predict the disease (55) , particuCorrespondence to: Gianluca Taccagni, MD, Cattedra di Anatomia e Istologia Patologica, Istituto Scientific0 H San Raffaele, Universiti degli Studi di Milano, Via Olgettina 60, 20132 Milano, Italia. with EIA. The specificity of both techniques towards insulin was assessed as the difference between the signals (number of gold particles per pm2 of insulin granule in IEM or optical density 20.193 in EIA) with and without excess insulin. Sensitivity was defined as the detection limit of the assay. In all the 10 sera investigated, E M was more sensitive, with a 12-to 40-fold lower detection limit than EIA. E M , with native insulin granules as substrate, is a specific, reproducible, and sensitive method for detection of human serum insulin antibodies. These findings also suggest E M as a procedure potentially suitable for identifying antigen specificity of autoantibodies circulating at low concentration. lady when they are detected at high titers (11) or in association with insulin antibodies (IA) ( 1,12,17,54,56 ). In fact, IA can develop not only in response to exogenous hormone administration (9,lO) but also spontaneously, either in insulin autoimmune hypoglycemic syndrome (25) or as part of the process of @-cell autoimmunity (2,3,17,18,28,39,40,54). This evidence is relatively recent, since these antibodies, owing to their low concentration, require very sensitive techniques to be detected (60) . The methods currently in use for IA measurement are RBA and EIA: however, although both sensitive and specific, these two techniques do not correlate with each other in IA measurement, possibly because of intrinsic differences of experimental conditions in the two assays (e.g., amount of ligand, epitope masking, conformational changes) (31-33,53,58,61). In the present study we report a newly developed technique to identify IA based on inmunoelectron microscopy (IEM) of human pancreas, which also allows direct visualization of the antigen-antibody reaction.
IEM assay has been developed by a procedure that preserves the antigenic integrity of the substrate rather than the morphological detail. The sensitivity of IEM, characterized as the detection limit of the assay, was compared to that of a competitive EIA performed in parallel on the same sera at the same dilutions. The specificity of IEM, characterized as the ability to detect no signals other than the one specific for insulin, was tested by displacement with excess antigen. This study established that IEM is a suitable method for detection of insulin antibodies.
Materials and Methods

Sera
Serum samples from 10 Type I diabetic patients treated with exogenous insulin with IA, and samples from 10 normal healthy controls without IA, detected by either RBA or EIA at different titers, were investigated (30,35,52,53). For comparison with IEM assay, only EIA results of IA measurement are considered in this study.
Enzymatic Immunoassay
An indirect and competitive EIA was performed as previously described (30, 53) . Briefly, insulin immobilized on a solid phase was allowed to react with serum samples. IgG bound to coated insulin interacted with mouse monoclonal antibodies (MAb) specific for total IGg. The fixation of mouse MAb antibody was subsequently detected with a horseradish peroxidaseconjugated rabbit anti-mouse IgG in the presence of a chromogenic substrate.
The sera studied did not undergo any purification process but were filtered with a 0.45-pm pore diameter filter. Each sample was tested at doubling dilutions from 1:25 to 1:25,600 in PBS, with and without an overnight pre-incubation with excess insulin (0.8 U/mg). Results were calculated as A optical density (OD), curves were drawn, and the titers at the cutoff were graphically determined. The cutoff, established at the 97.5th percentile of a control population, was equal to 0.193 OD. Interassay coefficients of variation in a 2-year period were 16.3% and 34.3% for OD of 0.9 and 0.3, respectively; an intraassay coefficient of variation was 19.7% for OD of 0.7.
ImmzlnoeZectron Microscopy Assay
Preparation of the Substrate. The substrate consisted of fresh human pancreas, obtained at the time of surgery, in which the antigen was represented by the insulin granule. Samples were obtained from several (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) fragments of normal tissue of about 1 mm2. Pancreatic samples were processed as described by Newman and Jasani (38). with minor modifications.
Samples were fixed for 2 hr in 4% paraformaldehyde in 0.1 M phosphate buffer, at room temperature, dehydrated in graded ethyl alcohol (15 min in 25% alcohol, 15 min in 50% alcohol, two treatments in 70% alcohol for 45 min each), placed in a mixture of acrylic resin (LR White:70% alcohol, 21) for 1 hr, and then in pure acrylic resin for 48 hr at room temperature. Each sample was then put in an airtight gelatin capsule and stored at 50°C for 48 hr.
Areas with a high density of well-preserved islets of Langerhans were identified by light microscopy of semi-thin 0.5 pm sections stained with methylene blue and safranin on a hotplate at 80°C. Subsequently, serial ultrathin 90-nm sections were mounted on 200-mesh nickel grids. In each pancreatic section with a surface of 500 pm2. insulin granules occupied a mean area of 9.52 pm'. The tissue samples embedded in Epon-Araldite were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, post-fixed in 1% 0~0 4 , and dehydrated in graded alcohol up to propylene oxide. Tissue sections were placed in droplets of 10% hydrogen peroxide for 25 min (4, 6, 16, 42) .
Immunolocalization. Immunolocalization was performed with the protein A-gold technique (5, 46, 47) . The sera were tested at increasing dilutions in PGB buffer (PBS + 1% bovine albumin + 1% glycine), pH 7.4.
The procedure consisted of the following steps. Pancreas sections were mounted on grids that were immersed in droplets of about 40 pl so that both surfaces of the section were wet. The sections were placed in PGB. pH 7.4, for 10 min. Excess PGB was removed with absorbent paper and the sections were left for 2 hr in the test serum at the following dilutions: 1:25, 1:100, 1:400, 1:1600, 1:6400, 1:21,600, and 1:102,400, in amoist chamber at 37°C (control sera were tested at 1:25 dilution only). The sections were then rinsed in PGB, pH 7.4, for 10 min and in two changes of PGB. pH 8.2, for 10 min each. The next step consisted of immersion for 1 hr in a solution of 10-nm diameter colloidal gold particles (CGP) at dilution of 1:50, pH 8.2, covered with protein A (Janssen; Olen, Belgium), in a moist chamber at 37°C. The sections were then placed in PGB, pH 8.2. for 5 min, in PGB, pH 7.4, for 5 min, and finally in double-distilled water, twice for 10 min. The grids thus labeled were then dried for 30 min and stained by floating them on drops of an alcoholic solution of uranyl acetate for 20 min at room temperature.
The sections were studied with an electron microscope (Zeiss CEM 902). Lead citrate staining was not performed, to avoid interference between possible lead precipitates and gold particles.
Assessment of Specificity. The following controls were performed with the aim of demonstrating the specificity (i.e., lack of crossreaction) of the antibody binding. (a) Antibodies were adsorbed with an excess of the corresponding antigen before incubation on substrate; each serum at the appropriate dilution was pre-incubated overnight at 4°C with a solution of highly purified DNA recombinant insulin (Actrapid HM 100; Novo Nordisk, Bagsvaerd, Denmark), at a concentration of 0.1 U/ml. (b) The sections were incubated with buffer (PGB) in place of the human serum.
Quantitative Evaluation. Each ultra-thin section was thoroughly scanned; well-preserved areas composed of P-cells were held in memory. Three of these areas, in which the density of insulin granules approximated the average density of insulin granules in the section, were photographed at an initial magnification of x 23,000 and analyzed at a final magnification of x 46,000. The mean intensity of antigen-antibody binding was quantified in these photographic fields by a computerized morphometer (MOP VIDEOPLAN) according to the procedure described by Bendayan et al. (7) . We calculated the ratio between the area occupied by insulin granules (Ag) and the number of gold particles (N) present in the same area, and obtained the density of the signal (D) from the formula D = N/Ag. This density was compared with that observed on the nuclei (aspecific background) and on consecutive sections of the same P-granules after incubation of sera with excess insulin, to assess the specificity of the antigen-antibody interaction; the significance of the differences was assessed with the Student's t-test.
The reproducibility of the method was determined by testing the sera in duplicate and by repeating titrations of two known positive sera in different assays. End-point titer was considered the last dilution at which the signal density on a granule was significantly higher than those observed on the same granules with excess insulin or on the nuclei. End-point titers obtained by IEM assay were compared with those obtained by EIA in each of the diabetes serum samples investigated.
Results
Electron microscopy of glutaraldehyde-fixed, Epon-embedded human pancreas showed good morphological detail of b-cells. The nucleus was round to oval, with dispersed and clumped chromatin; cytoplasm was rich in dense-core granules, often with a crystalline inner core, surrounded by a variably wide, clear halo and by a well-evident and continuous limiting membrane; well-developed Golgi complexes and RER were also observed. Immunoelectron microscopy on glutaraldehyde-fixed, Eponembedded tissue yielded consistently poor results; both the sensitivity and the specificity of antibody binding to insulin granules were very low with all sera tested. bcells had a poorly preserved morphology in paraformaldehydefixed, LR White-embedded thin sections. Although their nuclei were relatively well preserved, cytoplasmic organelles, except for the P-granules, were disrupted. The latter were scantily electron dense, occasionally had a well-defined crystalline inner core, and their limiting membrane was seldom preserved.
Conversely, the antigenicity, particularly of 0-cells, was well preserved in paraformaldehyde-fixed, LR White-embedded thin sections. IEM on thin sections of paraformaldehyde-fiued, LR Whiteembedded normal human pancreas, using sera of diabetic patients with different titers of IA, showed a sensitive and specific immunolocalization on insulin granules. Sera containing IA specifically immunostained the insulin granules; specific immunoreactivity (i.e., significantly higher than that observed in granule areas with excess insulin and in the nuclei) was maintained at increasing dilutions according to individual antibody concentration (Figures la-lc; Table 1 ). Minimal nonspecific labeling was observed on b-cell nuclei ( Figure Id) and on other cytoplasmic structures such as a-granules of glucagon-producing cells (Figure 2a ) or zymogen granules of acinar cells of the exocrine pancreas. For each of the 10 sera tested, the dilution curves demonstrated a sharp initial fall followed by a more gradual decrease of the antibody concentration (Figure 3) , except for serum 10; in this case, the curve was bell-shaped, probably due to the "prozone" effect caused by an excess of antibody, as occurs with other immunolocalization techniques. Antibody binding was totally or almost totally inhibited by absorption of insulin antibody-positive sera with excess insulin (Figure 2b ; Table 1 ). The sensitivity of the method, defined as the detection limit of the assay, was from 12-to 40-fold greater than that obtained with the EIA method ( Table 2 ).
The interassay coefficients of variation calculated for the two samples were 2.3 and 14.0%. No specific labeling on insulin granules was observed with sera from the 10 healthy human controls.
Discussion
At present, two methods are used to detect insulin antibodies, RBA and EIA, but their sensitivity varies in different studies (32, 57, 58) , and this has led to debate at the International Workshop for the Standardization of Insulin Antibodies (23, 32, 41, 59, 60) . Not all the sera tested by RBA and EIA demonstrated the same antibody titers with the two methods, for various reasons. RBA binding is mainly affected by affinity of the antibodies, whereas the EIA method is greatly dependent on the serum capacity (27,36,51). Furthermore, it has been demonstrated that monoiodinated insulin displays greater affinity than native insulin for certain antibodies (19, 24, 53) . This may explain part of the discrepancies between RBA and IEA. On the other hand, the possibility that some epitopes of the insulin molecule remain masked or distorted in a solid-phase EIA, thus becoming unavailable for the antigen-antibody reaction, cannot be ruled out (29, 53) .
Because of the presence of a high concentration of native antigen on a solid-phase in IEM, the results of IEM assay were compared with EIA. The IEM technique using colloidal gold particles has been known for some time to be useful and reliable in the localization of various classes of cell antigens (6, 22, 26, 44, (48) (49) (50) , although, to our knowledge, it has not been used to detect serum antibodies. The only IEM study performed with human sera as the source of specific antibodies dates back to 1977. The aim of that investigation was, however, to demonstrate the advantages offered by the protein A-colloidal gold complex with respect to the ferritin-antibody complex (45) .
Unlike the other immunohistochemical methods potentially available to determine insulin antibodies, IEM offers the advantage of high sensitivity without loss of specificity. In fact, the binding inhibition obtained by pretreating the sera tested with an excess of insulin indicated that the specificity of the method is also high. The IEM technique, based on the insulin antibody reaction with the P-granules, reveals the insulin in its physiological site, which has undergone the fixation and embedding steps necessary to preserve both the structural and the antigenic integrity of the (3-granules (8, 16, 37, 38, 43) . As in the case of EIA, it is, however, a solid-phase method, and the epitopes essential for antigen-antibody binding may be either masked or distorted. Immunolocalization on both surfaces of ultra-thin sections of tissue may, on the other hand, increase the amount of antigen available for antibody binding.
In conclusion, we have introduced a technique for ultrastructural immunolocalization that detects and measures the quantity of IA in the sera of diabetic patients. This technique may be of primary importance in cases in which, because of low insulin antibody titers, there is a high percentage of false negatives with the easier classic methods of RBA and EIA.
This study showed that, by IEM, positivity of sera is maintained at higher serum dilution than EIA. This might suggest a better efficiency in detecting low antibody titers.
In perspective the IEM assay could be useful to detect anti-insulin antibodies in sera negative by EIA and therefore to identify individuals at risk for development of Type I diabetes, thus increasing the accuracy of the disease prediction. Finally, our findings also suggest IEM as a suitable technique for identification and localization of new autoantigens in organ-or cell-specific autoimmune disorders, even those characterized by autoantibodies circulating at low concentrations.
